Top compounds associated with response to TDRP


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.059 0.2
mRNA piperlongumine GDSC1000 pan-cancer AAC 0.052 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.2
mRNA SR8278 CTRPv2 pan-cancer AAC 0.27 0.2
mRNA Midostaurin GDSC1000 pan-cancer AAC -0.054 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.2
mRNA Elesclomol GDSC1000 pan-cancer AAC 0.055 0.2
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.046 0.2
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.049 0.2
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.052 0.2
Download CSV